Abstract
Summary
Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate.
LPI (LP Information)' newest research report, the “Cough Suppressant Drugs Industry Forecast” looks at past sales and reviews total world Cough Suppressant Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Cough Suppressant Drugs sales for 2023 through 2029. With Cough Suppressant Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cough Suppressant Drugs industry.
This Insight Report provides a comprehensive analysis of the global Cough Suppressant Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cough Suppressant Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cough Suppressant Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cough Suppressant Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cough Suppressant Drugs.
The global Cough Suppressant Drugs market size is projected to grow from US$ 951.7 million in 2022 to US$ 1106.6 million in 2029; it is expected to grow at a CAGR of 2.2% from 2023 to 2029.
United States market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cough Suppressant Drugs players cover Perrigo Company, Vernalis, Tris Pharma, Pfizer, Acella Pharmaceuticals and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cough Suppressant Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Dry Cough
Wet Cough
Segmentation by application
Hospital
Retail Pharmacy
Online Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Perrigo Company
Vernalis
Tris Pharma
Pfizer
Acella Pharmaceuticals
GlaxoSmithKline
LPI (LP Information)' newest research report, the “Cough Suppressant Drugs Industry Forecast” looks at past sales and reviews total world Cough Suppressant Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Cough Suppressant Drugs sales for 2023 through 2029. With Cough Suppressant Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cough Suppressant Drugs industry.
This Insight Report provides a comprehensive analysis of the global Cough Suppressant Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cough Suppressant Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cough Suppressant Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cough Suppressant Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cough Suppressant Drugs.
The global Cough Suppressant Drugs market size is projected to grow from US$ 951.7 million in 2022 to US$ 1106.6 million in 2029; it is expected to grow at a CAGR of 2.2% from 2023 to 2029.
United States market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cough Suppressant Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cough Suppressant Drugs players cover Perrigo Company, Vernalis, Tris Pharma, Pfizer, Acella Pharmaceuticals and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cough Suppressant Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Dry Cough
Wet Cough
Segmentation by application
Hospital
Retail Pharmacy
Online Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Perrigo Company
Vernalis
Tris Pharma
Pfizer
Acella Pharmaceuticals
GlaxoSmithKline
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cough Suppressant Drugs Market Size 2018-2029
2.1.2 Cough Suppressant Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cough Suppressant Drugs Segment by Type
2.2.1 Dry Cough
2.2.2 Wet Cough
2.3 Cough Suppressant Drugs Market Size by Type
2.3.1 Cough Suppressant Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cough Suppressant Drugs Market Size Market Share by Type (2018-2023)
2.4 Cough Suppressant Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Cough Suppressant Drugs Market Size by Application
2.5.1 Cough Suppressant Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cough Suppressant Drugs Market Size Market Share by Application (2018-2023)
3 Cough Suppressant Drugs Market Size by Player
3.1 Cough Suppressant Drugs Market Size Market Share by Players
3.1.1 Global Cough Suppressant Drugs Revenue by Players (2018-2023)
3.1.2 Global Cough Suppressant Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Cough Suppressant Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cough Suppressant Drugs by Regions
4.1 Cough Suppressant Drugs Market Size by Regions (2018-2023)
4.2 Americas Cough Suppressant Drugs Market Size Growth (2018-2023)
4.3 APAC Cough Suppressant Drugs Market Size Growth (2018-2023)
4.4 Europe Cough Suppressant Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Cough Suppressant Drugs Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cough Suppressant Drugs Market Size by Country (2018-2023)
5.2 Americas Cough Suppressant Drugs Market Size by Type (2018-2023)
5.3 Americas Cough Suppressant Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cough Suppressant Drugs Market Size by Region (2018-2023)
6.2 APAC Cough Suppressant Drugs Market Size by Type (2018-2023)
6.3 APAC Cough Suppressant Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cough Suppressant Drugs by Country (2018-2023)
7.2 Europe Cough Suppressant Drugs Market Size by Type (2018-2023)
7.3 Europe Cough Suppressant Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cough Suppressant Drugs by Region (2018-2023)
8.2 Middle East & Africa Cough Suppressant Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Cough Suppressant Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cough Suppressant Drugs Market Forecast
10.1 Global Cough Suppressant Drugs Forecast by Regions (2024-2029)
10.1.1 Global Cough Suppressant Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Cough Suppressant Drugs Forecast
10.1.3 APAC Cough Suppressant Drugs Forecast
10.1.4 Europe Cough Suppressant Drugs Forecast
10.1.5 Middle East & Africa Cough Suppressant Drugs Forecast
10.2 Americas Cough Suppressant Drugs Forecast by Country (2024-2029)
10.2.1 United States Cough Suppressant Drugs Market Forecast
10.2.2 Canada Cough Suppressant Drugs Market Forecast
10.2.3 Mexico Cough Suppressant Drugs Market Forecast
10.2.4 Brazil Cough Suppressant Drugs Market Forecast
10.3 APAC Cough Suppressant Drugs Forecast by Region (2024-2029)
10.3.1 China Cough Suppressant Drugs Market Forecast
10.3.2 Japan Cough Suppressant Drugs Market Forecast
10.3.3 Korea Cough Suppressant Drugs Market Forecast
10.3.4 Southeast Asia Cough Suppressant Drugs Market Forecast
10.3.5 India Cough Suppressant Drugs Market Forecast
10.3.6 Australia Cough Suppressant Drugs Market Forecast
10.4 Europe Cough Suppressant Drugs Forecast by Country (2024-2029)
10.4.1 Germany Cough Suppressant Drugs Market Forecast
10.4.2 France Cough Suppressant Drugs Market Forecast
10.4.3 UK Cough Suppressant Drugs Market Forecast
10.4.4 Italy Cough Suppressant Drugs Market Forecast
10.4.5 Russia Cough Suppressant Drugs Market Forecast
10.5 Middle East & Africa Cough Suppressant Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Cough Suppressant Drugs Market Forecast
10.5.2 South Africa Cough Suppressant Drugs Market Forecast
10.5.3 Israel Cough Suppressant Drugs Market Forecast
10.5.4 Turkey Cough Suppressant Drugs Market Forecast
10.5.5 GCC Countries Cough Suppressant Drugs Market Forecast
10.6 Global Cough Suppressant Drugs Forecast by Type (2024-2029)
10.7 Global Cough Suppressant Drugs Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Perrigo Company
11.1.1 Perrigo Company Company Information
11.1.2 Perrigo Company Cough Suppressant Drugs Product Offered
11.1.3 Perrigo Company Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Perrigo Company Main Business Overview
11.1.5 Perrigo Company Latest Developments
11.2 Vernalis
11.2.1 Vernalis Company Information
11.2.2 Vernalis Cough Suppressant Drugs Product Offered
11.2.3 Vernalis Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Vernalis Main Business Overview
11.2.5 Vernalis Latest Developments
11.3 Tris Pharma
11.3.1 Tris Pharma Company Information
11.3.2 Tris Pharma Cough Suppressant Drugs Product Offered
11.3.3 Tris Pharma Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Tris Pharma Main Business Overview
11.3.5 Tris Pharma Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Cough Suppressant Drugs Product Offered
11.4.3 Pfizer Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Acella Pharmaceuticals
11.5.1 Acella Pharmaceuticals Company Information
11.5.2 Acella Pharmaceuticals Cough Suppressant Drugs Product Offered
11.5.3 Acella Pharmaceuticals Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Acella Pharmaceuticals Main Business Overview
11.5.5 Acella Pharmaceuticals Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Cough Suppressant Drugs Product Offered
11.6.3 GlaxoSmithKline Cough Suppressant Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
12 Research Findings and Conclusion